LCM
VIR icon

Landscape Capital Management’s Vir Biotechnology VIR Stock Holding History

Landscape Capital Management’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$91.2K Buy
+10,174
New +$81.1K 0.01% 686
2024
Q1 		– Sell
-48,606
Closed -$489K – 996
2023
Q4 		$489K Buy
+48,606
New +$444K 0.04% 416

Other funds holding VIR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
GP
GSK plc London $599M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Landscape Capital Management's VIR Position: Q1 2026 in Review

Landscape Capital Management opened a new position in Vir Biotechnology (VIR) in Q1 2026: 10,174 shares worth $91.2K. The stake represents 0.01% of the portfolio and ranks #686 among its holdings. This is a return to the name: Landscape Capital Management previously reported a position in VIR as recently as Q4 2023.

Landscape Capital Management first reported a position in VIR in Q4 2023 and has held it in 2 quarters since. The position peaked at $489K in Q4 2023. 251 funds tracked by Wall St. Rank hold VIR as of Q1 2026.

  • Landscape Capital Management held 10,174 shares of Vir Biotechnology worth $91.2K as of Q1 2026.
  • Vir Biotechnology was a new Landscape Capital Management position in Q1 2026.
  • Vir Biotechnology made up 0.01% of Landscape Capital Management's portfolio in Q1 2026, its #686 holding.
  • Landscape Capital Management first reported a position in Vir Biotechnology in Q4 2023 and has held it in 2 quarters since.
  • Landscape Capital Management's Vir Biotechnology position peaked at $489K in Q4 2023.
  • 251 funds tracked by Wall St. Rank held Vir Biotechnology as of Q1 2026.

Based on Landscape Capital Management's 13F filing for Q1 2026, filed 12 May 2026.